Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders.

Morisano D, Bacher I, Audrain-McGovern J, George TP.

Can J Psychiatry. 2009 Jun;54(6):356-67. Review.

PMID:
19527556
2.
3.

Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report.

Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, Breslau N, Brown RA, George TP, Williams J, Calhoun PS, Riley WT.

Nicotine Tob Res. 2008 Dec;10(12):1691-715. doi: 10.1080/14622200802443569.

PMID:
19023823
4.

A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder.

Weinberger AH, Vessicchio JC, Sacco KA, Creeden CL, Chengappa KN, George TP.

J Clin Psychopharmacol. 2008 Oct;28(5):584-7. doi: 10.1097/JCP.0b013e318184ba3c. No abstract available.

5.

Varenicline treatment for smokers with schizophrenia: a case series.

Evins AE, Goff DC.

J Clin Psychiatry. 2008 Jun;69(6):1016. No abstract available.

6.

Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia.

Dale Horst W, Klein MW, Williams D, Werder SF.

Neuropsychiatr Dis Treat. 2005 Dec;1(4):349-55.

7.

The case for treating tobacco dependence as a chronic disease.

Steinberg MB, Schmelzer AC, Richardson DL, Foulds J.

Ann Intern Med. 2008 Apr 1;148(7):554-6.

PMID:
18378950
8.

Nonpharmacologic therapy for smoking cessation: characteristics and efficacy of current approaches.

Niaura R.

Am J Med. 2008 Apr;121(4 Suppl 1):S11-9. doi: 10.1016/j.amjmed.2008.01.021. Review.

PMID:
18342162
9.

A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses.

Gallagher SM, Penn PE, Schindler E, Layne W.

J Psychoactive Drugs. 2007 Dec;39(4):487-97.

PMID:
18303706
10.

Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.

Berk M, Ng F, Wang WV, Tohen M, Lubman DI, Vieta E, Dodd S.

J Affect Disord. 2008 Sep;110(1-2):126-34. doi: 10.1016/j.jad.2008.01.018. Epub 2008 Feb 15.

PMID:
18280579
11.

Eliminating tobacco use in mental health facilities: patients' rights, public health, and policy issues.

Williams JM.

JAMA. 2008 Feb 6;299(5):571-3. doi: 10.1001/jama.299.5.571. No abstract available.

PMID:
18252888
12.

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.

George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, Feingold A, Jatlow PI.

Biol Psychiatry. 2008 Jun 1;63(11):1092-6. Epub 2007 Dec 21.

13.

Outcome from a community-based smoking cessation program for persons with serious mental illness.

Currie SR, Karltyn J, Lussier D, de Denus E, Brown D, El-Guebaly N.

Community Ment Health J. 2008 Jun;44(3):187-94. Epub 2007 Nov 30.

PMID:
18049896
14.

Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.

Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe M, Sutherland G.

Addiction. 2008 Jan;103(1):146-54. Epub 2007 Nov 19.

PMID:
18028247
15.

Treatment of tobacco dependence: integrating recent progress into practice.

Le Foll B, George TP.

CMAJ. 2007 Nov 20;177(11):1373-80. Review. Erratum in: CMAJ. 2008 Mar 11;178(6):732.

16.

Nicotine interventions with comorbid populations.

Hall SM.

Am J Prev Med. 2007 Dec;33(6 Suppl):S406-13. Review.

PMID:
18021916
17.

Smoking cessation treatment in community-based substance abuse rehabilitation programs.

Reid MS, Fallon B, Sonne S, Flammino F, Nunes EV, Jiang H, Kourniotis E, Lima J, Brady R, Burgess C, Arfken C, Pihlgren E, Giordano L, Starosta A, Robinson J, Rotrosen J.

J Subst Abuse Treat. 2008 Jul;35(1):68-77. Epub 2007 Oct 24.

PMID:
17951021
18.

Bupropion and nicotine patch as smoking cessation aids in alcoholics.

Grant KM, Kelley SS, Smith LM, Agrawal S, Meyer JR, Romberger DJ.

Alcohol. 2007 Aug;41(5):381-91.

19.

A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.

Evins AE, Cather C, Culhane MA, Birnbaum A, Horowitz J, Hsieh E, Freudenreich O, Henderson DC, Schoenfeld DA, Rigotti NA, Goff DC.

J Clin Psychopharmacol. 2007 Aug;27(4):380-6.

PMID:
17632223
20.

Tobacco smoking within psychiatric inpatient settings: biopsychosocial perspective.

Olivier D, Lubman DI, Fraser R.

Aust N Z J Psychiatry. 2007 Jul;41(7):572-80. Review.

PMID:
17558619

Supplemental Content

Support Center